TABLE 1.
Patient | Age at Onset of Signs or Symptoms | Initial Symptoms and Signs | Age at Presentation for Medical Care | Symptoms and Signs at Presentation for Medical Care | Clinical-laboratory Results at Presentation*
|
Procedure(s); age | Indication | Age at the Last Follow-up | |
---|---|---|---|---|---|---|---|---|---|
GGT | ALT | ||||||||
1 | 16 wk | Jaundice, hepatomegaly, bruising | 5 mo | Pruritus, hepatomegaly | 14 | 236 | Biliary diversion, 17 mo | Pruritus | 41 mo |
2 | 6 mo | Jaundice, pruritus | 17 mo | Pruritus | 14 | 145 | Ileal exclusion, 13 mo Transplant, 28 mo |
Pruritus Continued pruritus |
86 mo |
3 | ND | ND | 9 mo | Jaundice, pruritus | 14 | 93 | None | NA | 30 mo |
4 | 8 wk | Jaundice | 8 wk | Jaundice, scleral icterus | 39 | 569 | Transplant, 20 mo | Cirrhosis, pruritus | 92 mo |
5 | ND | ND | 30 mo | Jaundice, diarrhea | 58 | 199 | Transplant, 37 mo | ND | 37 mo |
6† | 1 mo | Jaundice | 6 mo | Jaundice, pruritus, failure to thrive, hepatomegaly, scleral icterus | 35 | 959 | Biliary diversion, 11 mo Transplant, 16 mo |
Pruritus Portal hypertension, coagulopathy, ascites |
3 y |
7 | 6 wk | Poor weight gain | 13 mo | Intermittent jaundice, intermittent pruritus, hepatosplenomegaly | 35 | 60 | Ileal exclusion, 9 y | Pruritus | 15 y |
8 | 3 mo | Pruritus | 8 mo | Jaundice, pruritus, hepatomegaly, scleral icterus | 29 | 254 | Ileal exclusion, 15 mo | Pruritus | 65 mo |
9 | 2 mo | Jaundice, scleral icterus | 7 y | Pruritus, poor growth, intermittent abdominal pain and distention | 19 | 130 | Transplant, 88 mo | Cirrhosis | 92 mo |
10 | 8 mo | Jaundice | 21 mo | Jaundice, pruritus, poor growth, hepatosplenomegaly | 24 | 164 | Biliary diversion, 22 mo | Pruritus | 23 mo |
11 | 4 mo | Intracranial hemorrhage | 4 mo | Coagulation abnormalities, mild hepatomegaly | 19 | 285 | Transplant, 62 mo | Pruritus | 70 mo |
12 | 3 mo | Jaundice, pruritus | 6 wk | None (affected sibling) | 33 | 259 | Transplant, 17 mo | Pruritus | 18 mo |
Expected ranges for these analytes are not provided because they were measured at different institutions and at different times.
Patient 6 was included in a recent report of gene mutations in children with cholestasis.13
ALT indicates alanine transaminase; GGT, γ-glutamyltransferase; NA indicates not applicable; ND, not determined (unknown).